1. Home
  2. LODE vs ANTX Comparison

LODE vs ANTX Comparison

Compare LODE & ANTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Comstock Inc.

LODE

Comstock Inc.

HOLD

Current Price

$3.22

Market Cap

211.8M

Sector

Industrials

ML Signal

HOLD

Logo AN2 Therapeutics Inc.

ANTX

AN2 Therapeutics Inc.

HOLD

Current Price

$5.95

Market Cap

172.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LODE
ANTX
Founded
1999
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
211.8M
172.9M
IPO Year
2004
2022

Fundamental Metrics

Financial Performance
Metric
LODE
ANTX
Price
$3.22
$5.95
Analyst Decision
Hold
Buy
Analyst Count
2
1
Target Price
$4.00
$2.00
AVG Volume (30 Days)
886.7K
206.1K
Earning Date
05-11-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
63.55
32.56
EPS
N/A
N/A
Revenue
$1,553,796.00
N/A
Revenue This Year
$1,582.85
N/A
Revenue Next Year
$246.20
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.35
$1.00
52 Week High
$4.98
$7.19

Technical Indicators

Market Signals
Indicator
LODE
ANTX
Relative Strength Index (RSI) 41.06 56.34
Support Level $3.08 $3.91
Resistance Level $3.38 $7.05
Average True Range (ATR) 0.21 0.35
MACD -0.01 -0.04
Stochastic Oscillator 17.65 58.02

Price Performance

Historical Comparison
LODE
ANTX

About LODE Comstock Inc.

Comstock Inc commercializes technologies that convert underutilized waste and natural resources into clean energy and supporting products, including electrification, metals, and minerals from end-of-life solar panels. Its subsidiary focuses on producing renewable fuels from waste, energy crops, and woody biomass, supported by facilities in Wisconsin, pilot farms, a biorefinery site in Tulsa, and solar panel recycling operations in Nevada. The Company operates through two high-growth segments and a corporate segment, with its activities grouped into Metals, which generates the majority of revenue, Fuels, Mining, Strategic Investments, and Corporate Services.

About ANTX AN2 Therapeutics Inc.

AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology. Product candidate AN2-502998 Epetraborole.

Share on Social Networks: